Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 46.1 | 40.3 | 37.6 | 33.0 | 34.1 | 37.2 | 29.5 | 18.7 |
| Revenue growth | 14.3% | 7.2% | 13.8% | -3.1% | -8.5% | 26.2% | 58.0% | -21.0% |
| Cost of goods sold | 12.7 | 11.4 | 10.8 | 9.9 | 8.9 | 10.5 | 9.0 | 4.3 |
| Gross profit | 33.3 | 28.9 | 26.8 | 23.1 | 25.2 | 26.7 | 20.5 | 14.3 |
| Gross margin | 72.4% | 71.6% | 71.4% | 70.0% | 74.0% | 71.8% | 69.6% | 76.8% |
| Sales and marketing | 12.3 | 10.4 | 9.7 | 10.5 | 11.4 | 11.0 | 8.5 | 7.8 |
| Research and development | 20.7 | 40.2 | 37.0 | 35.3 | 29.4 | 19.5 | 14.4 | 10.6 |
| General and administrative | 4.5 | 4.2 | 3.8 | 3.7 | 3.4 | 4.2 | 4.5 | 2.4 |
| EBIT | -4.1 | -5.5 | -4.6 | -7.8 | -3.5 | 2.6 | 1.1 | -0.4 |
| EBIT margin | -8.9% | -13.6% | -12.2% | -23.7% | -10.2% | 7.0% | 3.8% | -2.0% |
| Pre-tax income | -2.1 | -5.1 | -3.8 | -6.7 | -2.4 | 3.0 | 1.9 | -0.8 |
| Income taxes | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.1 |
| Tax rate | | | | | | 2.8% | 1.2% | |
| Net income | -2.3 | -5.3 | -4.0 | -6.8 | -2.4 | 2.9 | 1.9 | -0.9 |
| Net margin | -4.9% | -13.1% | -10.6% | -20.7% | -7.1% | 7.8% | 6.5% | -4.9% |
| |
| Diluted EPS | | ($0.37) | ($0.29) | ($0.50) | ($0.18) | $0.23 | $0.18 | ($0.11) |
| Shares outstanding (diluted) | | 14.1 | 13.9 | 13.8 | 13.6 | 12.4 | 10.8 | 8.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|